Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2026-05-15

SEC-registered investment adviser since 2023 · limited liability company

As an employer

$895.1m reported value +2.3% vs Q4 2025
33positions
50.5%in top 10
5 new 17 added 11 reduced 5 sold out vs Q4 2025

Holdings, Q1 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 104,726 $62.1m6.94% 6.94% AddedShares held: Q2 2025 0, Q3 2025 85.3k, Q4 2025 63.6k, Q1 2026 104.7k +41.1k +41,146 64.7%
2 ABIVAX SA SPONSORED ADS ABVX ABVX 465,869 $51.9m5.80% 5.80% AddedShares held: Q2 2025 0, Q3 2025 291.8k, Q4 2025 381.2k, Q1 2026 465.9k +84.6k +84,636 22.2%
3 BRIDGEBIO PHARMA INC COM BBIO BBIO 695,718 $51.7m5.77% 5.77% AddedShares held: Q2 2025 551.7k, Q3 2025 589.7k, Q4 2025 595.5k, Q1 2026 695.7k +100.2k +100,245 16.8%
4 XENON PHARMACEUTICALS INC COM XENE XENE 786,844 $45.8m5.11% 5.11% ReducedShares held: Q2 2025 660.6k, Q3 2025 799.7k, Q4 2025 799.7k, Q1 2026 786.8k -12.9k -12,899 -1.6%
5 REVOLUTION MEDICINES INC COM RVMD RVMD 468,376 $45.5m5.09% 5.09% ReducedShares held: Q2 2025 415.6k, Q3 2025 643.0k, Q4 2025 638.4k, Q1 2026 468.4k -170.0k -170,009 -26.6%
6 APOGEE THERAPEUTICS INC COM COM 513,770 $43.2m4.83% 4.83% AddedShares held: Q2 2025 311.5k, Q3 2025 402.8k, Q4 2025 474.8k, Q1 2026 513.8k +38.9k +38,931 8.2%
7 INSMED INC COM PAR $.01 INSM INSM 248,475 $40.6m4.54% 4.54% ReducedShares held: Q2 2025 372.7k, Q3 2025 319.8k, Q4 2025 264.3k, Q1 2026 248.5k -15.8k -15,818 -6.0%
8 NUVALENT INC COM COM 370,344 $37.9m4.24% 4.24% AddedShares held: Q2 2025 320.8k, Q3 2025 394.8k, Q4 2025 368.7k, Q1 2026 370.3k +1.6k +1,647 0.5%
9 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 400,464 $37.0m4.13% 4.13% ReducedShares held: Q2 2025 527.5k, Q3 2025 570.6k, Q4 2025 481.6k, Q1 2026 400.5k -81.1k -81,100 -16.8%
10 COGENT BIOSCIENCES INC COM COGT COGT 947,339 $36.5m4.07% 4.07% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 824.3k, Q1 2026 947.3k +123.1k +123,056 14.9%
11 ROIVANT SCIENCES LTD SHS ROIV ROIV 1,190,118 $33.0m3.68% 3.68% AddedShares held: Q2 2025 0, Q3 2025 959.7k, Q4 2025 1.2m, Q1 2026 1.2m +3.3k +3,301 0.3%
12 AXSOME THERAPEUTICS INC COM AXSM AXSM 188,772 $31.9m3.56% 3.56% ReducedShares held: Q2 2025 144.4k, Q3 2025 152.6k, Q4 2025 206.9k, Q1 2026 188.8k -18.1k -18,149 -8.8%
13 IDEAYA BIOSCIENCES INC COM IDYA IDYA 873,838 $29.1m3.25% 3.25% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 723.7k, Q1 2026 873.8k +150.2k +150,185 20.8%
14 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,017,284 $25.6m2.86% 2.86% AddedShares held: Q2 2025 2.0m, Q3 2025 2.2m, Q4 2025 2.0m, Q1 2026 2.0m +7.0k +6,977 0.3%
15 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 623,839 $24.5m2.73% 2.73% NewShares held: Q2 2025 510.0k, Q3 2025 783.4k, Q4 2025 0, Q1 2026 623.8k
16 CELCUITY INC COM CELC CELC 210,578 $24.0m2.69% 2.69% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 210.6k
17 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 446,390 $21.9m2.45% 2.45% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 459.7k, Q1 2026 446.4k -13.3k -13,337 -2.9%
18 KYMERA THERAPEUTICS INC COM KYMR KYMR 254,672 $21.2m2.37% 2.37% AddedShares held: Q2 2025 0, Q3 2025 277.7k, Q4 2025 206.4k, Q1 2026 254.7k +48.2k +48,227 23.4%
19 CYTOKINETICS INC COM NEW CYTK CYTK 283,700 $18.7m2.09% 2.09% ReducedShares held: Q2 2025 0, Q3 2025 254.8k, Q4 2025 325.7k, Q1 2026 283.7k -42.0k -41,968 -12.9%
20 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 220,921 $18.5m2.07% 2.07% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 220.9k
21 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 148,093 $18.5m2.06% 2.06% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 148.1k
22 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 558,336 $17.9m2.00% 2.00% ReducedShares held: Q2 2025 521.1k, Q3 2025 717.0k, Q4 2025 893.5k, Q1 2026 558.3k -335.1k -335,137 -37.5%
23 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 911,337 $17.8m1.99% 1.99% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 690.5k, Q1 2026 911.3k +220.8k +220,809 32.0%
24 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 76,300 $17.5m1.95% 1.95% ReducedShares held: Q2 2025 134.7k, Q3 2025 146.3k, Q4 2025 131.8k, Q1 2026 76.3k -55.5k -55,508 -42.1%
25 FULCRUM THERAPEUTICS INC COM FULC FULC 2,256,109 $17.3m1.93% 1.93% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 1.9m, Q1 2026 2.3m +363.4k +363,426 19.2%
26 TERNS PHARMACEUTICALS INC COM COM 326,694 $17.2m1.92% 1.92% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 872.0k, Q1 2026 326.7k -545.4k -545,355 -62.5%
27 VERA THERAPEUTICS INC CL A VERA VERA 422,023 $17.0m1.90% 1.90% ReducedShares held: Q2 2025 309.7k, Q3 2025 354.5k, Q4 2025 601.8k, Q1 2026 422.0k -179.8k -179,751 -29.9%
28 NATERA INC COM NTRA NTRA 81,077 $16.2m1.81% 1.81% AddedShares held: Q2 2025 118.1k, Q3 2025 80.9k, Q4 2025 80.9k, Q1 2026 81.1k +202 +202 0.2%
29 ERASCA INC COM ERAS ERAS 867,639 $14.0m1.57% 1.57% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 867.6k
30 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 42,441 $13.7m1.53% 1.53% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 35.7k, Q1 2026 42.4k +6.7k +6,692 18.7%
31 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 768,662 $11.5m1.28% 1.28% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 617.7k, Q1 2026 768.7k +150.9k +150,948 24.4%
32 UNIQURE NV SHS QURE QURE 615,489 $10.1m1.12% 1.12% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 321.7k, Q1 2026 615.5k +293.8k +293,834 91.3%
33 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 315,563 $5.9m0.66% 0.66% AddedShares held: Q2 2025 0, Q3 2025 262.6k, Q4 2025 262.6k, Q1 2026 315.6k +52.9k +52,920 20.1%

Sold out since Q4 2025

SecurityTickerShares held beforeValue then
GUARDANT HEALTH INC GH GH 271,685 $27.7m271.7k shares
ARGENX SE ARGX ARGX 23,256 $19.6m23.3k shares
RHYTHM PHARMACEUTICALS INC RYTM RYTM 146,303 $15.7m146.3k shares
ARCUS BIOSCIENCES INC RCUS RCUS 565,142 $13.5m565.1k shares
DISC MEDICINE INC IRON IRON 153,206 $12.2m153.2k shares